These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Assessment of sustained effects of levosimendan and dobutamine on left ventricular systolic functions by using novel tissue Doppler derived indices in patients with advanced heart failure. Oner E; Erturk M; Birant A; Kurtar Mansıroglu A; Akturk IF; Karakurt H; Yalcin AA; Uzun F; Somuncu MU; Yildirim A Cardiol J; 2015; 22(1):87-93. PubMed ID: 24846511 [TBL] [Abstract][Full Text] [Related]
6. Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure. Adamopoulos S; Parissis JT; Iliodromitis EK; Paraskevaidis I; Tsiapras D; Farmakis D; Karatzas D; Gheorghiade M; Filippatos GS; Kremastinos DT Am J Cardiol; 2006 Jul; 98(1):102-6. PubMed ID: 16784930 [TBL] [Abstract][Full Text] [Related]
7. Acute effects of levosimendan on mitral regurgitation and diastolic function in patients with advanced chronic heart failure. Branzi G; Malfatto G; Villani A; Ciambellotti F; Revera M; Giglio A; Rosa FD; Facchini M; Parati G J Cardiovasc Med (Hagerstown); 2010 Sep; 11(9):662-8. PubMed ID: 20613551 [TBL] [Abstract][Full Text] [Related]
8. [Intensive care for newborns and babies of the first year of life with acute heart failure after cardiosurgical interventions]. Lobacheva GV; Khar'kin AV; Manerova AF; Dzhobava ER Anesteziol Reanimatol; 2010; (5):23-7. PubMed ID: 21400728 [TBL] [Abstract][Full Text] [Related]
9. Use of levosimendan, a new inodilator, for postoperative myocardial stunning in a premature neonate. Lechner E; Moosbauer W; Pinter M; Mair R; Tulzer G Pediatr Crit Care Med; 2007 Jan; 8(1):61-3. PubMed ID: 17149153 [TBL] [Abstract][Full Text] [Related]
10. Levosimendan improves hemodynamic status in critically ill patients with severe aortic stenosis and left ventricular dysfunction: an interventional study. García-González MJ; Jorge-Pérez P; Jiménez-Sosa A; Acea AB; Lacalzada Almeida JB; Ferrer Hita JJ Cardiovasc Ther; 2015 Aug; 33(4):193-9. PubMed ID: 25959786 [TBL] [Abstract][Full Text] [Related]
11. Cardiovascular effects of the calcium sensitizer, levosimendan, in heart failure induced by rapid pacing in the presence of aortic constriction. Udvary E; Papp JG; Végh A Br J Pharmacol; 1995 Feb; 114(3):656-61. PubMed ID: 7735692 [TBL] [Abstract][Full Text] [Related]
12. Prophylactic treatment with levosimendan: a retrospective matched-control study of patients with reduced left ventricular function. Kolseth SM; Nordhaug DO; Stenseth R; Sellevold O; Kirkeby-Garstad I; Wahba A Eur J Cardiothorac Surg; 2009 Dec; 36(6):1024-30. PubMed ID: 19592266 [TBL] [Abstract][Full Text] [Related]
14. Levosimendan in patients with low-output heart failure: lessons from the LIDO trial. Follath F Ital Heart J; 2003 May; 4 Suppl 2():34S-38S. PubMed ID: 14635368 [TBL] [Abstract][Full Text] [Related]
15. Hemodynamic support of a 15-year-old waiting for a heart transplant: Is there a role for levosimendan in pediatric heart failure? Goyer I; Brossier D; Toledano B Arch Pediatr; 2018 Feb; 25(2):132-135. PubMed ID: 29395891 [TBL] [Abstract][Full Text] [Related]